Vaginal progesterone for preterm birth prevention in women with arrested preterm labor

References

• Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–456.
   PubMed Web of Science ®Google Scholar
• Committee on Practice Bulletins-Obstetrics TACoO, Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol. 2012;120(4):964–973.
   PubMedGoogle Scholar
• Goldenberg RL, Iams JD, Mercer BM, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU network. Am J Public Health. 1998;88(2):233–238.
   PubMed Web of Science ®Google Scholar
• American College of O, Gynecologists' Committee on Practice B-O. Practice bulletin no. 171: management of preterm labor. Obstet Gynecol. 2016;128(4):e155–164.
   Google Scholar
• Lyell DJ, Pullen KM, Mannan J, et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol. 2008;112(6):1221–1226.
   PubMed Web of Science ®Google Scholar
• Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2013;(5):CD000940.
   PubMed Web of Science ®Google Scholar
• Stelzl P, Kehl S, Rath W. Maintenance tocolysis: a reappraisal of clinical evidence. Arch Gynecol Obstet. 2019;300(5):1189–1199.
   PubMed Web of Science ®Google Scholar
• van Vliet E, Dijkema GH, Schuit E, et al. Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis. BJOG. 2016;123(11):1753–1760.
   PubMed Web of Science ®Google Scholar
• Suhag A, Saccone G, Berghella V. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 2015;213(4):479–487.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Vergani P, Di Tommaso M, et al. Progestogens for maintenance tocolysis in women with a short cervix: a randomized controlled trial. Obstet Gynecol. 2017;130(1):64–70.
   PubMed Web of Science ®Google Scholar
• Hyett J, Asadi N, Zare Khafri M, et al. The use of vaginal progesterone as a maintenance therapy in women with arrested preterm labor: a double-blind placebo-randomized controlled trial. J Matern Fetal Neonatal Med. 2020;1–7.
   PubMedGoogle Scholar
• Martinez de Tejada B, the 4P trial group, Karolinski A, et al. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. BJOG: Int J Obstet Gy. 2015;122(1):80–91.
   PubMed Web of Science ®Google Scholar
• Palacio M, the PROMISE Collaborative Group, Cobo T, et al. Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial. BJOG: Int J Obstet Gy. 2016;123(12):1990–1999.
   PubMed Web of Science ®Google Scholar
• Lotfalizadeh M, Kz Maleki A, Najaf Najafi M. Comparison of the duration of pregnancy in administration of progesterone suppository and duphaston tablet in pregnant women with preterm labor after stopping delivery process. Iranian J Obstetrics Gyencology Infertility. 2019;22(10):1–11.
   Google Scholar
• Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Deeks JJ, Egger M, et al. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007;8(2):239–251.
   PubMed Web of Science ®Google Scholar
• Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2008;48(1):58–63.
   PubMed Web of Science ®Google Scholar
• Sharami SZZ, Shakiba M, Milani F. Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: a randomized placebo-controlled double blind trial. Int J Fert Steril. 2010;4(2):45–50.
   Web of Science ®Google Scholar
• Arikan I, Barut A, Harma M, et al. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. Gynecol Obstet Invest. 2011;72(4):269–273.
   PubMed Web of Science ®Google Scholar
• Gargari SSH, Zonobi Z, Khani Z, et al. Outcome of vaginal progesterone as a tocolytic agent: randomized clinical trial. ISRN Obstet Gynecol. 2012;2012:607906–607905.
   PubMedGoogle Scholar
• Areia A, Fonseca E, Moura P. Progesterone use after successful treatment of threatened pre-term delivery. J Obstet Gynaecol. 2013;33(7):678–681.
   PubMedGoogle Scholar
• Lotfalizadeh M, Ghomian N, Saeedian H. The effects of progesterone therapy on the gestation length and reduction of neonatal complications in patients who had received tocolytic therapy for acute phase of preterm labor. Iran Red Crescent Med J. 2013;15(10):e7947.
   PubMed Web of Science ®Google Scholar
• Wood S, Rabi Y, Tang S, et al. Progesterone in women with arrested premature labor, a report of a randomised clinical trial and updated meta-analysis. BMC Pregnancy Childbirth. 2017;17(1):258.
   PubMedGoogle Scholar
• Blackwell SC, Gyamfi-Bannerman C, Biggio JR, et al. 17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial. Am J Perinatol. 2020;37(02):127–136.
   PubMed Web of Science ®Google Scholar
• Manuck TA, Stoddard GJ, Fry RC, et al. Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. Am J Obstet Gynecol. 2016;215(5):622 e621–622.e628.
   PubMed Web of Science ®Google Scholar